In June 2026, the Central Drugs Standards Organisation (CDSCO) released updated guidelines for the import of active pharmaceutical ingredients (APIs), tightening documentation and traceability requirements for manufacturers and importers. The new rules, effective 1 July 2026, mandate enhanced Certificate of Analysis (CoA) verification, batch-level origin attestation, and quarterly supplier audits.
For Indian manufacturers relying on imported APIs—particularly those in contract manufacturing, generics, and fixed-dose combinations—this creates an immediate compliance window. Delayed action risks import rejection, production halts, and potential penalty notices.
Market signals
CDSCO now requires manufacturers to independently verify third-party CoAs against original laboratory test reports within 15 days of shipment arrival. Digital submission via the e-Samadhan portal is mandatory; paper submissions are no longer accepted.
Importers must conduct on-site or remote audits of API suppliers at least once per quarter. Audit reports must include GPS-tagged facility photographs and batch-to-batch traceability logs, stored for five years.
From 1 September 2026, all API import declarations must integrate with CDSCO's e-Prabandh system. Non-integrated filings will face automatic 30-day processing delays and re-submission demands.
Under India's Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945, CDSCO holds authority to set import eligibility criteria. Non-compliance with these June 2026 guidelines may attract show-cause notices, temporary import suspension, and manufacturing-licence consequences under Rule 96. Manufacturers must immediately audit existing supplier relationships, validate CoA authenticity, and establish quarterly audit schedules. Vinayakam Consultants helps pharma and chemical manufacturers map their current API supply chain against the new CoA and audit requirements, prepare supplier scorecards, and file compliant import declarations on e-Samadhan and e-Prabandh without processing delays.
Your action checklist
- Within 7 days: Obtain and review the full June 2026 CDSCO API import guidelines from the official portal; identify all active API suppliers and cross-check their current CoA formats against the new verification template.
- Within 14 days: Conduct an internal audit of existing API batches in stock; verify that CoAs were issued within 12 months and contain mandatory fields (purity, moisture, microbial limits, batch lot number, manufacturing date, expiry).
- Within 30 days: Schedule Q3 2026 supplier audits (on-site or remote) for all API vendors; prepare audit checklists aligned to CDSCO's facility-inspection criteria and ensure GPS-tagged photographs and batch records are documented.
- By 1 August 2026: Test-upload a sample API import declaration via e-Samadhan and e-Prabandh systems; confirm integration functionality and address any portal login or certificate errors before the 1 September 2026 mandatory cut-off.
Frequently asked questions
CDSCO's updated guidelines mandate enhanced Certificate of Analysis verification within 15 days, quarterly supplier audits with geo-tagged photographs, and mandatory e-Prabandh system integration from September 2026 for all API imports.
Non-compliance may result in show-cause notices, temporary import suspension, manufacturing licence consequences, import rejections, production halts, and penalty notices under the Drugs and Cosmetics Act.
No. Digital submission via the e-Samadhan portal is now mandatory; paper submissions are no longer accepted for CoA verification under the June 2026 guidelines.